GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine – Dr Jitendra Singh launched the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine. Gennova, with funding support from the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC), developed India’s first mRNA vaccine using indigenous platform technology.
- GEMCOVAC® -OM is the 5th vaccine developed with support from Mission COVID Suraksha implemented by DBT and BIRAC under the Atmanirbhar Bharat 3.0 package of Govt. of India for accelerated development of Indian COVID-19 vaccines.
- GEMCOVAC® -OM is a thermostable vaccine and does not need ultra-cold chain infrastructure used for other approved mRNA- based vaccines.
- The GEMCOVAC® -OM vaccine will be delivered intra-dermally using a needle-free injection device system and in study participants, it generated significantly higher immune responses.